YD Bio Limited Ordinary Shares (YDES) Earnings History
Annual and quarterly earnings data from 2020 to 2024
Loading earnings history...
YDES EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
YDES Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 30.4% | -286.5% | -276.6% |
| 2023 | 43.8% | -2.8% | 3.9% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export YDES earnings history in CSV or JSON format
Free sign-in required to download data
YD Bio Limited Ordinary Shares (YDES) Earnings Overview
As of May 8, 2026, YD Bio Limited Ordinary Shares (YDES) reported trailing twelve-month net income of -$3M. The company earned $-0.87 per diluted share over the past four quarters, with a net profit margin of -276.6%.
Looking at the long-term picture, YDES's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2021.
YD Bio Limited Ordinary Shares is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BTBT ($137M net income, 17.3% margin), NUVB (-$146M net income, -325.3% margin), ZLAB (-$176M net income, -38.1% margin), YDES has room to improve margins relative to the peer group. Compare YDES vs BTBT →
YDES Earnings vs Peers
Earnings metrics vs comparable public companies
YDES Historical Earnings Data (2020–2024)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$1M | -10509.7% | -$1M | $-0.56 | -276.6% | -286.5% |
| 2023 | $13,560 | -99.6% | $-9,847 | $0.00 | 3.9% | -2.8% |
| 2022 | $4M | -56.5% | -$2M | $0.41 | - | - |
| 2021 | $9M | +443.0% | -$2M | $0.59 | - | - |
| 2020 | -$3M | - | $-344,223 | $-0.17 | - | - |
See YDES's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs YDES Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare YDES vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonYDES — Frequently Asked Questions
Quick answers to the most common questions about buying YDES stock.
Is YDES growing earnings?
YDES TTM EPS: $-0.87. Net income: $-3M. Earnings growth: N/A.
What are YDES's profit margins?
YD Bio Limited Ordinary Shares net margin is -276.6%, with operating margin at -286.5%. Below-average margins reflect competitive or cost pressures.
How consistent are YDES's earnings?
YDES earnings data spans 2020-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.